109 related articles for article (PubMed ID: 13991539)
1. Wilson's disease and the concentration of caeruloplasmin in serum.
SCHEINBERG IH; STERNLIEB I
Lancet; 1963 Jun; 1(7296):1420-1. PubMed ID: 13991539
[No Abstract] [Full Text] [Related]
2. Caeruloplasmin in Wilson's disease.
ROSENOER VM; FRANGLEN G
Lancet; 1959 Dec; 2(7113):1163-4. PubMed ID: 14439030
[No Abstract] [Full Text] [Related]
3. The heterogeneity of caeruloplasmin nd the enzymatic defect in Wilson's disease.
RICHTERICH R; GAUTIER E; STILLHART H; ROSSI E
Helv Paediatr Acta; 1960 Nov; 15():424-36. PubMed ID: 13741432
[No Abstract] [Full Text] [Related]
4. Caeruloplasmin isoforms in Wilson's disease in neonates.
Chowrimootoo GF; Scowcroft H; Seymour CA
Arch Dis Child Fetal Neonatal Ed; 1998 Nov; 79(3):F198-201. PubMed ID: 10194991
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).
SCHEINBERG IH; GITLIN D
Science; 1952 Oct; 116(3018):484-5. PubMed ID: 12994898
[No Abstract] [Full Text] [Related]
6. Relation of ceruloplasmin and plasma copper to hepatolenticular degeneration (Wilson's disease).
SCHEINBERG IH
Prog Neurobiol (1956); 1956; 1():52-63. PubMed ID: 13359521
[No Abstract] [Full Text] [Related]
7. New insights into the pathogenesis of copper toxicosis in Wilson's disease: evidence for copper incorporation and defective canalicular transport of caeruloplasmin.
Chowrimootoo GF; Ahmed HA; Seymour CA
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):851-5. PubMed ID: 8645167
[TBL] [Abstract][Full Text] [Related]
8. Immunocytochemical identification of caeruloplasmin in hepatocytes of patients with Wilson's disease.
Graul RS; Epstein O; Sherlock S; Scheuer PJ
Liver; 1982 Sep; 2(3):207-11. PubMed ID: 6184593
[TBL] [Abstract][Full Text] [Related]
9. Observations on ceruloplasmin in Wilson's disease.
SASS-KORTSAK A; CHERNIAK M; GEIGER DW; SLATER RJ
J Clin Invest; 1959 Oct; 38(10 Pt 1-2):1672-82. PubMed ID: 14441876
[No Abstract] [Full Text] [Related]
10. Studies on the oxidase properties of ceruloplasmin: factors in normal and Wilson's-disease serum affecting oxidase activity.
WALSHE JM
J Clin Invest; 1963 Jul; 42(7):1048-53. PubMed ID: 13998657
[No Abstract] [Full Text] [Related]
11. [Clinico-biological considerations on a case of Wilson's disease with normal ceruloplasmin levels].
REBUCCI GG; TASSINARI CA
Riv Patol Nerv Ment; 1962 Sep; 83():498-518. PubMed ID: 13973459
[No Abstract] [Full Text] [Related]
12. [Tests of ceruloplasmin substitution in hepatocerebral degeneration (Wilson's disease)].
BICKEL H; GOLLNER I; GRUTER W; SCHULTZE HE
Klin Wochenschr; 1956 Sep; 34(35-36):961-8. PubMed ID: 13377617
[No Abstract] [Full Text] [Related]
13. Reduced oxidase activity in the caeruloplasmin of two families with Wilson's disease.
Gollan JL; Stocks J; Dormandy TL; Sherlock S
J Clin Pathol; 1977 Jan; 30(1):81-3. PubMed ID: 838874
[TBL] [Abstract][Full Text] [Related]
14. [COPPER METABOLISM AND WILSON'S DISEASE].
LANGE J
Verh Dtsch Ges Inn Med; 1964; 70():330-7. PubMed ID: 14294237
[No Abstract] [Full Text] [Related]
15. Metabolic aspects of Wilson's disease: a review.
SIMPSON JF
Med Bull (Ann Arbor); 1963; 29():145-54. PubMed ID: 13977562
[No Abstract] [Full Text] [Related]
16. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
SCHEINBERG IH; MORELL AG
J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
[No Abstract] [Full Text] [Related]
17. WILSON'S DISEASE (HEPATO-LENTICULAR DEGENERATION): A BRIEF REVIEW.
HELLER GL
Psychiatry Dig; 1965 Mar; 26():33-9. PubMed ID: 14256542
[No Abstract] [Full Text] [Related]
18. Molecular studies of ceruloplasmin deficiency in Wilson's disease.
Czaja MJ; Weiner FR; Schwarzenberg SJ; Sternlieb I; Scheinberg IH; Van Thiel DH; LaRusso NF; Giambrone MA; Kirschner R; Koschinsky ML
J Clin Invest; 1987 Oct; 80(4):1200-4. PubMed ID: 3654978
[TBL] [Abstract][Full Text] [Related]
19. [WILSON'S DISEASE TREATED BY PENICILLAMINE].
BERNHEIM M; FREYCON MT; PELLET H; DEFFRENNE P; LAMIT J
Pediatrie; 1964; 19():373-5. PubMed ID: 14147228
[No Abstract] [Full Text] [Related]
20. Serum ceruloplasmin oxidase activity is a sensitive and highly specific diagnostic marker for Wilson's disease.
Merle U; Eisenbach C; Weiss KH; Tuma S; Stremmel W
J Hepatol; 2009 Nov; 51(5):925-30. PubMed ID: 19720421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
